Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 22'nd Oct 2024
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 19'th Aug 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
BBH: Buy Rating, As Tech Investors Look Beyond FAANG
05:12am, Tuesday, 23'rd Jul 2024
Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innov
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
06:00am, Wednesday, 26'th Jun 2024
I'm on the hunt for ‘Strong Buy' biotech stocks. According to Finviz.com, there are 680 U.S.-listed biotech stocks.
Biotech ETF (BBH) Hits New 52-Week High
08:00am, Tuesday, 25'th Jun 2024
VanEck Biotech ETF BBH is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 21.4% from its 52-week low price of $142.51/share.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Monday, 17'th Jun 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
BOSTON--(BUSINESS WIRE)--As the ETF industry reaches a milestone of $12.71 trillion in global assets, the Brown Brothers Harriman 2024 Global ETF Investor Survey finds that investors plan to further i
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Monday, 15'th Apr 2024
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Why Biotech Stocks May Be Ready For A Recovery
03:59am, Saturday, 09'th Mar 2024
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stoc
Where Are Biotech ETFs Headed After Q4 Earnings?
05:51pm, Wednesday, 14'th Feb 2024
Look into how Biotech ETFs performed after Q4 earnings.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 12'th Feb 2024
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Biotech ETFs Stage Solid Comeback at the Start of 2024
12:47pm, Tuesday, 09'th Jan 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
AI Advancements Could Be Boon for Biotech Industry
10:07am, Wednesday, 03'rd Jan 2024
Generative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
07:57pm, Friday, 15'th Dec 2023
NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2023 annual distributions per share for its VanEck® equity exchange-traded funds.
BBH: A Solid Way To Play A Comeback In Biotech
11:08am, Saturday, 09'th Dec 2023
Biotech sector has potential for outperformance in the next year. VanEck Biotech ETF is a good product to consider for exposure to the sector. BBH focuses on large-cap biotech stocks, offering a more
